Literature DB >> 24622103

Characterization of multidrug-resistant group B streptococci with reduced penicillin susceptibility forming small non-Beta-hemolytic colonies on sheep blood agar plates.

Hirotsugu Banno1, Kouji Kimura2, Yosuke Tanaka3, Hiromitsu Kitanaka1, Wanchun Jin1, Jun-ichi Wachino4, Keiko Yamada1, Keigo Shibayama5, Yoshichika Arakawa4.   

Abstract

We isolated and characterized three multidrug-resistant clinical isolates of group B streptococci with reduced penicillin susceptibility (PRGBS) that formed small non-beta-hemolytic colonies on sheep blood agar plates but grew well on chocolate agar plates. They can be overlooked in the bacterial identification step, leading to clinical misdiagnosis and treatment failure.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24622103      PMCID： PMC4042806          DOI： 10.1128/JCM.00226-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  15 in total

1.  Erythromycin and clindamycin resistance in group B streptococcal clinical isolates.

Authors:  Scott E Gygax; Jessica A Schuyler; Lauren E Kimmel; Jason P Trama; Eli Mordechai; Martin E Adelson
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

2.  Erythromycin resistance and genetic elements carrying macrolide efflux genes in Streptococcus agalactiae.

Authors:  José María Marimón; Adoración Valiente; María Ercibengoa; José M García-Arenzana; Emilio Pérez-Trallero
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

3.  Evaluation of a new method for identification of bacteria based on sequence homology of 16S rRNA gene.

Authors:  T Sasaki; T Nishiyama; M Shintani; T Kenri
Journal:  PDA J Pharm Sci Technol       Date:  1997 Nov-Dec

4.  Nosocomial spread of multidrug-resistant group B streptococci with reduced penicillin susceptibility belonging to clonal complex 1.

Authors:  Noriyuki Nagano; Yukiko Nagano; Masami Toyama; Kouji Kimura; Takashi Tamura; Keigo Shibayama; Yoshichika Arakawa
Journal:  J Antimicrob Chemother       Date:  2011-12-29       Impact factor: 5.790

5.  Transport of multidrug resistance substrates by the Streptococcus agalactiae hemolysin transporter.

Authors:  Birgit Gottschalk; Gerd Bröker; Melanie Kuhn; Simone Aymanns; Ute Gleich-Theurer; Barbara Spellerberg
Journal:  J Bacteriol       Date:  2006-08       Impact factor: 3.490

Review 6.  Group B streptococcus.

Authors:  A Schuchat
Journal:  Lancet       Date:  1999-01-02       Impact factor: 79.321

7.  The putative glycosyltransferase-encoding gene cylJ and the group B Streptococcus (GBS)-specific gene cylK modulate hemolysin production and virulence of GBS.

Authors:  Marie-Pierre Forquin; Asmae Tazi; Manuel Rosa-Fraile; Claire Poyart; Patrick Trieu-Cuot; Shaynoor Dramsi
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

8.  First molecular characterization of group B streptococci with reduced penicillin susceptibility.

Authors:  Kouji Kimura; Satowa Suzuki; Jun-ichi Wachino; Hiroshi Kurokawa; Kunikazu Yamane; Naohiro Shibata; Noriyuki Nagano; Haru Kato; Keigo Shibayama; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2008-05-19       Impact factor: 5.191

9.  Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics.

Authors:  Samira Dahesh; Mary E Hensler; Nina M Van Sorge; Robert E Gertz; Stephanie Schrag; Victor Nizet; Bernard W Beall
Journal:  Antimicrob Agents Chemother       Date:  2008-06-09       Impact factor: 5.191

10.  High frequency of fluoroquinolone- and macrolide-resistant streptococci among clinically isolated group B streptococci with reduced penicillin susceptibility.

Authors:  Kouji Kimura; Noriyuki Nagano; Yukiko Nagano; Satowa Suzuki; Jun-ichi Wachino; Keigo Shibayama; Yoshichika Arakawa
Journal:  J Antimicrob Chemother       Date:  2012-10-30       Impact factor: 5.790
View more
  4 in total

1.  Antimicrobial susceptibilities of group B streptococcus isolates from prenatal screening samples.

Authors:  Benjamin R Berg; Jeana L Houseman; Zachary E terSteeg; William D LeBar; Duane W Newton
Journal:  J Clin Microbiol       Date:  2014-07-16       Impact factor: 5.948

2.  Molecular Characterization of Nonhemolytic and Nonpigmented Group B Streptococci Responsible for Human Invasive Infections.

Authors:  Anne Six; Arnaud Firon; Céline Plainvert; Camille Caplain; Abdelouhab Bouaboud; Gérald Touak; Nicolas Dmytruk; Magalie Longo; Franck Letourneur; Agnès Fouet; Patrick Trieu-Cuot; Claire Poyart
Journal:  J Clin Microbiol       Date:  2015-10-21       Impact factor: 5.948

3.  Non-hemolytic group B streptococcus as a cause of chemotherapy port infection.

Authors:  Ray-Young Tsao; Larry Lutwick
Journal:  IDCases       Date:  2017-08-31

4.  Analysis of multidrug resistant group B streptococci with reduced penicillin susceptibility forming small, less hemolytic colonies.

Authors:  Hirotsugu Banno; Kouji Kimura; Yosuke Tanaka; Tsuyoshi Sekizuka; Makoto Kuroda; Wanchun Jin; Jun-Ichi Wachino; Keiko Yamada; Keigo Shibayama; Yoshichika Arakawa
Journal:  PLoS One       Date:  2017-08-17       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.